Cagrillentide (amylin) development plans

Rita explains cagrillentide's mechanism as an amylin analog and upcoming phase 3 recruitment for monotherapy trials.

Play episode from 04:44

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!